Vaccines
Massachusetts Attorney General Maura Healey joined a coalition of 12 attorneys general in calling on Facebook and Twitter to take stronger measures to stop the spread of anti-vaxxer coronavirus disinformation on their social media platforms. The coalition, led by Connecticut Attorney General William Tong, sent letters to Facebook CEO Mark
Vaccines
The attorneys general of eleven states have written to Facebook and Twitter CEOs Mark Zuckerberg and Jack Dorsey, expressing concerns over the spread of anti-vaxxer disinformation on their social media platforms. The letters urge both companies to take stronger measures to prevent the spread of false information about coronavirus vaccines,
AstraZeneca PLC
Results from a large clinical trial in the United States and South America indicate that AstraZeneca's COVID-19 vaccine, AZD1222, is well-tolerated and protects against symptomatic COVID-19 disease, including severe disease or hospitalization. The vaccine demonstrated statistically significant efficacy of 78.9% in preventing symptomatic COVID-19 and 100% efficacy
COVID-19 vaccines
The Philippine Food and Drug Administration (FDA) has yet to receive official applications for emergency use authorization (EUA) from three COVID-19 vaccine manufacturers: Johnson & Johnson, Moderna, and Sinopharm. Despite holding talks with American companies Johnson & Johnson and Moderna on the requirements for obtaining regulatory approval, no applications have
Vaccines
The first patient in a Phase I/IIa clinical trial of BT-001, a novel dual mechanism-of-action oncolytic vaccinia virus, has been enrolled at the Institut Bergonie in Bordeaux, France. BT-001 is being co-developed by BioInvent and Transgene through a 50/50 collaboration and combines multiple mechanisms-of-action to target the tumor
Vaccines
As the COVID-19 vaccine continues to roll out, Governor Ned Lamont and Attorney General William Tong are urging residents to be cautious of scams targeting those seeking immunization. The scammers, posing as vaccine manufacturers, send consumers deceptive emails and texts, often with fake rewards or payments, in an attempt to
COVID-19 vaccines
AstraZeneca's safety review of over 17 million people who received its COVID-19 vaccine in the EU and the UK found no evidence of an increased risk of blood clots, pulmonary embolism, deep vein thrombosis, or thrombocytopenia. The review was conducted after several countries temporarily suspended the use of
COVID-19 vaccines
Ohio is continuing to add to its list of coronavirus vaccine providers as the state works to distribute vaccines to residents. The state's efforts are part of a federal retail pharmacy program that aims to reach high-risk individuals and further the vaccination process. With new pharmacies joining the
COVID-19 vaccines
Ukrainian President Volodymyr Zelensky announced on Monday that the country has reached agreements with four major pharmaceutical companies, including Pfizer, Sinovac, AstraZeneca, and Novavax, to obtain COVID-19 vaccines. This significant development comes as Ukraine prepares to launch its vaccination campaign, with the first stage targeting medical professionals, military personnel, and
COVID-19 vaccines
The development of COVID-19 vaccines has led to promising results, with multiple vaccines demonstrating high efficacy against the virus. The vaccines, developed by various companies and institutions, have taken different approaches to creating immunity against COVID-19. COVID-19 vaccines have undergone extensive testing, with some showing remarkable results. Key Takeaways: * Pfizer
COVID-19 vaccines
BP's fourth-quarter results, out on Tuesday, will be followed by US oil giants ExxonMobil and Conoco-Phillips, as the world's largest energy companies navigate a challenging landscape. With the global economy fighting to recover from the COVID-19 pandemic, investors will be keenly watching for signs of a
COVID-19 vaccines
The European Union has stepped up its pressure on pharmaceutical companies that received EU aid to develop coronavirus vaccines, warning them to deliver shots on schedule at a time when infections are surging and many EU member states are struggling to roll out vaccines efficiently. The EU has invested heavily
